Collaborative Practice Agreement · PharmD

Virginia Written Collaborative Agreement for Pharmacists

Required. The Written Collaborative Agreement is the written instrument Virginia law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.

Practice authoritySupervision required
Written agreementAgreement required
What Virginia calls itWritten Collaborative Agreement
Governing boardVirginia Board of Pharmacy
Agreement familyCollaborative Practice
Research date2026-08-12 · clauses 2026-09-03

Represents Virginia's pharmacist Collaborative Practice Agreement (CPA) tier, not ordinary licensure — base dispensing and statutory limited authority need no physician agreement and are out of scope here. Unlike NC, VA has no named credential and no board-certification/residency/experience requirement — any licensed pharmacist 'involved in patient care' may enter a CPA. No numeric cap per physician was found. Regs were amended effective Nov. 5, 2025 — that amendment's substance couldn't be fully confirmed; verify before treating details below as current.

What a Virginia Written Collaborative Agreement must contain

Governed by the Virginia Board of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.

  1. The Pharmacist shall practice pursuant to a written collaborative agreement with the Physician, as required by Va. Code § 54.1-3300.1, defining cooperative procedures for treatment using drug therapy, laboratory tests, or medical devices, for the purpose of improving patient outcomes. The collaborative agreement may authorize the Pharmacist to prescribe, modify, continue, or discontinue drug therapy, order laboratory tests, or otherwise manage or monitor drug or device therapy, but only for conditions with protocols that are clinically accepted as the standard of care or approved by the Virginia Boards of Medicine and Pharmacy, and only after diagnosis by the Physician or another licensed practitioner authorized to diagnose.

    Source: Va. Code § 54.1-3300.1

  2. Before the Pharmacist prescribes, modifies, continues, or discontinues a Schedule II through V controlled substance under the collaborative agreement, the Pharmacist shall submit a signed copy of the agreement to the Virginia Board of Pharmacy and obtain the Board's authorization for that activity. No collaborative agreement may exceed the scope of practice of either Party, and no patient may be required to participate in a collaborative procedure without the patient's consent.

  3. The Written Collaborative Agreement on file also carries 1 scope, 1 education, 1 registration clauses, generated in the document itself.

Statutes and rules cited

  1. Va. Code § 54.1-2957statute

    Licensure and practice of advanced practice registered nurses, including the practice agreement requirement (subsection C/D) and the autonomous-practice attestation pathway for experienced nurse practitioners (subsection I). Contains no numerical cap on the number of nurse practitioners a physician may serve as patient care team physician for.

  2. Va. Code §§ 54.1-2952, 54.1-2952.01statute

    Six-physician-assistant-per-physician cap (§ 54.1-2952) and the autonomous-practice attestation pathway for physician assistants with three years/1,800 hours-per-year of full-time clinical experience (§ 54.1-2952.01).

  3. Va. Code § 54.1-3300.1statute

    Authorizes pharmacist-practitioner collaborative agreements for drug therapy, lab test, and device management, including Board of Pharmacy authorization required before prescribing Schedule II-V controlled substances under such an agreement.

Terms it has to carry

Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.

Proximity

Not codified — left to the agreement

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Not codified — left to the agreement

Prescriptive authority

Covered by the practice agreement · controlled substances permitted

May prescribe, modify, continue, or discontinue drug therapy per protocol following diagnosis by the collaborating practitioner, order labs, and adjust/manage device therapy (§ 54.1-3300.1). Schedule II–VI controlled substances are explicitly authorized, but only after the pharmacist submits the signed CPA to the Board of Pharmacy and obtains specific authorization — not automatic.

Written agreement

Required

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — No pharmacist-ownership requirement — § 54.1-3434 expressly allows non-pharmacist/corporate pharmacy ownership; a licensed pharmacist-in-charge (PIC) must retain full professional control over dispensing, which the owner 'shall not abridge.'

Materially more permissive than the healing-arts/APRN PC/PLLC regime above.

Legal sources for these rules (4)
How the relationship works day to day
Who has to be where, how often you meet, and what the physician costs: Pharmacist in Virginia on collaborativeagreement.com.

About Virginia's rules

No provider type below has a codified chart-review percentage, countersignature rule, or numeric proximity radius — all are left to the practice agreement. CPOM (ownership) is governed by Title 13.1's PC/PLLC statutes, which explicitly list APRNs (NP/CRNA/CNM/CNS) as eligible independent owners but do not enumerate PAs — the PA ownership pathway is an inference from that omission, not a confirmed holding. Virginia has no independent corporate-practice-of-medicine common-law doctrine (a 1992 AG opinion, secondary-sourced only).

Other clinicians in Virginia: see the state overview.